Contract Manufacturing News: Breaking Contract Manufacturing News, Comments and Articles. - Page: 2

17:24 EDT 2nd September 2014 | BioPortfolio

Contract Manufacturing News - Page: 2Twitter RSS

Read the latest Contract Manufacturing News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Contract Manufacturing.

Search or Follow Our Contract Manufacturing - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Contract Manufacturing - Page: 2 News.
You can also follow our Contract Manufacturing - Page: 2 news stories on Twitter: @cro_bio

Showing "contract manufacturing" News Articles 26 to 50 of 7,800+

Tuesday 2nd September 2014

PMI® at 59%; August Manufacturing ISM® Report On Business®; New Orders, Employment and Production Growing; Inventories Growing; Supplier Deliveries Slowing

DO NOT CONFUSE THIS NATIONAL REPORT with the various regional purchasing reports released across the country. The national report's information reflects the entire United States, while the regional reports contain primarily regional data from their local vicinities. Also, the information in the regional reports is not used in calculating the results of the national report. The information compiled...

Aethlon Medical Announces Receipt of IRB Approval to Initiate Hemopurifier® Clinical Studies

SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB: AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, announced today that it has received independent internal review board (IRB) approval to initiate human clinical studies of Hemopurifier® therapy at DaVita MedCenter Dialysi...

Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline

DUBLIN, Sept. 2, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Actavis' New Drug Application (NDA) for eluxadoline, an investigational drug for the treatment of diarrhea and abdominal pain in men and women with diarrhea predominant Irritable Bowel Syndrome (IBS-D).  Actavis' NDA for eluxadoline has been gr...

DUX Dental Kicks Off 2014 Bib-Eze For Boob-Eze Campaign To Benefit Breast Cancer Charity

OXNARD, Calif., Sept. 2, 2014 /PRNewswire/ -- Today, DUX Dental kicks off the sixth-annual "Bib-Eze for Boob-Eze" campaign to benefit Barbells for Boobs, a non-profit breast cancer organization that is dedicated to the early detection of breast cancer, with an emphasis on women and men under the age of 40. During the Bib-Eze for Boob-Eze program, dental offices are invited to take a photo of ...

States To Help Pay Obamacare Tax On Insurers

When Congress passed the Affordable Care Act, it required health insurers, hospitals, device makers and pharmaceutical companies to share in the cost because they would get a windfall of new, paying customers.  But with an $8 billion tax on insurers due Sept. 30 -- the first time the new tax is being collected -- the industry is getting help from an unlikely source: taxpayers. State...

Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients

SAN CARLOS, Calif., Sept. 2, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it has entered into an Exclusive Channel Collaboration (ECC) with Sanofi Chimie, a wholly owned subsidiary of Sanofi (EURONEXT: SAN and NYSE: SNY) to develop an enhanced production process for a specific family of its marketed Active Pharmaceutical Ingredient...

Constructions Workers Diagnosed with Mesothelioma are Provided with Instant Access and Ideal Results from Compensation Lawyers through the Mesothelioma Compensation Center

WASHINGTON, Sept. 2, 2014 /PRNewswire/ -- The Mesothelioma Compensation Center says, "If a diagnosed victim of mesothelioma, or their family members, are concerned about getting the best possible compensation for this rare form of cancer caused by asbestos exposure, we are urging them to call us at 866-714-6466 before they retain the services of a separate firm to advance a mesothelioma ...

Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th

SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the Rodman and Renshaw 16th Annual Global Investment Conference on Tuesday, September 9, 2014 at 2:55 p.m. Eastern time in the Holmes II Salon at The New York Palace Hotel in New York. Interested parties can access a l...

Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency

THOUSAND OAKS, Calif., Sept. 2, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) via the centralized procedure for talimogene laherparepvec seeking approval for the treatment of adults with melanoma that is regionally or distantly metastatic. Talimogene laherparepvec is an investi...

Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension

SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the US Food and Drug Administration (FDA) has granted orphan drug status to APD811 for the treatment of pulmonary arterial hypertension. "The FDA Office of Orphan Products Development (OOPD) evaluates scientific and clinical data submissions from sponsors to identify and designate drug c...

Albemarle completes sale of antioxidant, ibuprofen and propofol businesses to SI Group

BATON ROUGE, La., Sept. 2, 2014 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB) today announced the successful completion of the previously announced sale of its antioxidant, ibuprofen and propofol businesses and related assets to SI Group, Inc.  The transaction includes manufacturing sites in Orangeburg, South Carolina and Jinshan, China.  Certain applications and technical support ca...

Galmed Pharmaceuticals Completes Two Chronic Toxicology Studies and Reports No Significant Adverse Events

TEL-AVIV, Israel, Sept. 2, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones, announced today that it successfully completed two six-month chronic toxicology studies of its drug candidate, ...

Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection

SUNNYVALE, Calif., Sept. 2, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection. The test will be marketed as a CE-IVD product under the European Directive on In Vitro Diagnostic Medical Devices, bringing the total...

BIOREM announces $2.1 million of new orders

GUELPH, ON, Sept. 2, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced three new orders totalling $2.1 million. The orders consist of three large odour control systems for waste water treatment plants in Canada. "These orders are consistent with the market resurgence in North America," said Peter Bruijns, President and CEO. "After a difficult period of r...

Sinovac to Participate in Upcoming Investor Conferences

BEIJING, Sept. 2, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company's management will participate in the following investor conferences in September: Morgan Stanley Global Healthcare Conference, to be held at the Grand Hyatt New York on September 9 and 10, 2014. Morgan Stanley Asia Pacific He...

Contract Research Organization WCCT Global Celebrates Being Named as One of the Fastest Growing Companies in America

COSTA MESA, Calif., Sept. 2, 2014 /PRNewswire-iReach/ -- WCCT Global, a multi-site contract research organization was just recognized as one of the fastest growing companies in America by INC 5000. Over the past few years, the company has undergone significant growth in four main areas: early phase clinical research, late phase global clinical development, anti-viral and vaccine development, and p...

E-Cigarettes May Be Safer, But They're Still Harmful

Rayshell Clapper for redOrbit.com - Your Universe Online According to the Centers for Disease Control and Prevention (CDC), the single most easily preventable cause of death and disease is to eliminate tobacco use. Smoking can lead to many health issues including respiratory, cancer, heart disease, and blood problems. Over 480,000 Americans die each year due to cigarette smoking, and 41,000 of th...

Monday 1st September 2014

Water Automation and Instrumentation Market by Process stage (Collection, Treatment and Distribution), Automation Technology, Instrumentation, End user Application and Geography - Analysis & Forecast (2014 - 2020)

Recently added to the BioPortfolio report store, Water Automation and Instrumentation Market by Process stage (Collection, Treatment and Distribution), Automation Technology, Instrumentation, End user Application and Geography - Analysis & Forecast (2014 - 2020) is a new report from Markets and Markets published on 2014-08-25. This 282-page report is available from $4650. The automation and ...

Feed Yeast Market by Type (Live Yeast, Spent Yeast and Yeast Derivatives), by Livestock & by Geography - Global Trends & Forecasts to 2019

Recently added to the BioPortfolio report store, Feed Yeast Market by Type (Live Yeast, Spent Yeast and Yeast Derivatives), by Livestock & by Geography - Global Trends & Forecasts to 2019 is a new report from Markets and Markets published on 2014-08-26. This 140-page report is available from $4650. By Geography - Global Trends & Forecasts to 2019 The animal feed yeast market is booming d...

Mexico Factory Automation and Machine Vision Market by Technology (ICS, MES, ERP, ITS), Field Devices, Products (PC-based, Smart Camera, Embedded), Components (Camera, FGOL), Application (Process, Discrete) - Global Forecast & Analysis to 2013 - 2020

Recently added to the BioPortfolio report store, Mexico Factory Automation and Machine Vision Market by Technology (ICS, MES, ERP, ITS), Field Devices, Products (PC-based, Smart Camera, Embedded), Components (Camera, FGOL), Application (Process, Discrete) - Global Forecast & Analysis to 2013 - 2020 is a new report from Markets and Markets published on 2014-06-25. This 386-page report is avail...

Frost & Sullivan Presents Goodwin Biotechnology with the Global Customer Value Leadership Award for Mammalian Biologics Contract Manufacturing

LONDON, Sept. 2, 2014 /PRNewswire/ -- Based on its recent analysis of the mammalian contract manufacturing services market, Frost & Sullivan recognises Goodwin Biotechnology with the 2014 Global Frost & Sullivan Award for Customer Value Leadership. Goodwin Biotechnology's reputation as one of the most trusted providers of mammalian contract manufacturing and development services has been b...

Threshold Pharmaceuticals Announces Presentation and Webcast at the Rodman & Renshaw 16th Annual Global Investment Conference

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/02/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at the Rodman & Renshaw 16th Annual Global Investment Conference on Tuesday, September 9, 2014, at 10:50 a.m. Eastern Time. A live webcast of the presentation will be available und...

Xtalks Announces Its September and October 2014 Webinars

TORONTO, ON--(Marketwired - September 02, 2014) - Join us for our calendar of free webinars, which features insightful discussions about clinical trials, market access, drug development, patient participation, clinical labeling, pharmacovigilance, drug safety, supply chain, extractables and leachables, and co employment. Learn about current industry hot topics through free webinars which will be ...

LED Medical Diagnostics Announces a New Board Chair and New Directors

BURNABY, BC--(Marketwired - September 02, 2014) - LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or "the Company") today announces that Darryl J. Yea has accepted the position of Chair of the Board and Director of the Company. Mr. Yea has served as a director of LED Medical since 2011. He is the President of Investco Capital Management Inc. "We are...

MacAulay-Brown, Inc. Named to Multi-billion Dollar OASIS IDIQ Contract to Deliver Complex, Integrated Technology Services

DAYTON, Ohio, Sept. 2, 2014 (GLOBE NEWSWIRE) -- MacAulay-Brown, Inc. (MacB), a leading National Security company delivering advanced engineering services and product solutions to Defense, Intelligence, Special Operations Forces, Homeland Security and Federal agencies, announced today that it has been awarded a major Indefinite-delivery/Indefinite-quantity (IDIQ) contract by the Government Service...


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks